CMND

Clearmind Medicine Inc. NASDAQ Listed Nov 15, 2022

Healthcare ·Biotechnology ·CA · clearmindmedicine.com

$0.56

Mkt Cap $76,201

52w Low $0.52 0.1% of range 52w High $52.40

50d MA $0.92 200d MA $17.21

P/E (TTM) -0.0x

EV/EBITDA -0.5x

P/B 0.1x

Debt/Equity 1.5x

ROE —

P/FCF -0.9x

RSI (14) —

ATR (14) —

Beta -1.03

50d MA $0.92

200d MA $17.21

Avg Volume 4.9M

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

SIC Code

2834

CIK (SEC)

1892500

Phone

604 260 1566

1220 West 6th Avenue · Vancouver, BC V6H 1A5 · CA

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 12, 2026	AMC	—	-3.32	—	0.83	+0.2%	-5.9%	-5.1%	+1.4%	-9.8%	-3.1%	—
Jan 28, 2026	AMC	—	-4.40	—	2.52	-0.4%	-13.1%	-0.9%	+2.8%	-5.8%	-16.2%	—
Sep 11, 2025	AMC	—	-10.00	—	42.00	-1.0%	-2.9%	+1.0%	-1.9%	+1.0%	-2.0%	—
Jun 12, 2025	AMC	—	-6.40	—	34.25	-0.6%	+0.3%	+1.3%	-3.2%	+2.1%	+3.1%	—
Mar 13, 2025	AMC	—	-9.60	—	45.20	+0.0%	+0.9%	+0.0%	+5.3%	-3.3%	+0.9%	—
Jan 22, 2025	AMC	—	-0.11	—	58.00	+4.1%	+2.8%	-1.3%	-6.1%	-0.7%	+0.0%	—
Sep 16, 2024	AMC	—	-0.59	—	53.20	+2.3%	+0.8%	-1.5%	-2.3%	-6.2%	+0.0%	—
Jun 13, 2024	AMC	—	-0.28	—	43.20	+1.9%	+2.8%	+0.0%	+10.8%	+4.1%	+13.3%	—
Mar 18, 2024	AMC	—	-0.90	—	52.00	+1.5%	-0.8%	-5.4%	+1.6%	-4.8%	-1.7%	—
Jan 29, 2024	AMC	—	-629.09	—	59.20	+0.7%	-2.7%	-0.7%	+20.3%	+6.4%	-3.8%	—
Sep 13, 2023	AMC	—	-0.08	—	480.00	-43.8%	-54.0%	-2.2%	-1.7%	+0.0%	-5.6%	—
Jun 14, 2023	AMC	—	-906.13	—	645.60	-1.5%	+1.3%	-1.1%	-3.3%	-4.0%	-9.4%	—

Data updated apr 25, 2026 1:59am · Source: massive.com